in this issue
People & Business :: M&A
BASF to begin squeeze-out process for Pronova, plans to finalize deal in first quarter
10:53 AM MST | January 21, 2013 | Natasha Alperowicz
BASF announced today that its cash offer to shareholders of Pronova BioPharma (Lysaker, Norway), which ended on 18 January 2013, resulted in 293,975,655 Pronova shares being tendered. This corresponds to 97.7% of all Pronova shares. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be almost 5 billion Norwegian kroner ($892.4 million). BASF says that all regulatory approvals required for completion of the voluntary offer have been obtained. The next step in the acquisition process...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee